McLeod HL - Search Results

1

Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin.

Gage BF, Eby C, Johnson JA, Deych E, Rieder MJ, Ridker PM, Milligan PE, Grice G, Lenzini P, Rettie AE, Aquilante CL, Grosso L, Marsh S, Langaee T, Farnett LE, Voora D, Veenstra DL, Glynn RJ, Barrett A, McLeod HL. Gage BF, et al. Among authors: mcleod hl. Clin Pharmacol Ther. 2008 Sep;84(3):326-31. doi: 10.1038/clpt.2008.10. Epub 2008 Feb 27. Clin Pharmacol Ther. 2008. PMID: 18305455 Free PMC article.

2

Pharmacokinetic study of infusional valspodar.

Ma MK, McLeod HL, Westervelt P, Fracasso PM. Ma MK, et al. Among authors: mcleod hl. J Clin Pharmacol. 2002 Apr;42(4):412-8. J Clin Pharmacol. 2002. PMID: 11936566

3

SNP databases and pharmacogenetics: great start, but a long way to go.

Marsh S, Kwok P, McLeod HL. Marsh S, et al. Among authors: mcleod hl. Hum Mutat. 2002 Sep;20(3):174-9. doi: 10.1002/humu.10115. Hum Mutat. 2002. PMID: 12203989

4

Thymidylate synthase pharmacogenetics in colorectal cancer.

Marsh S, McLeod HL. Marsh S, et al. Among authors: mcleod hl. Clin Colorectal Cancer. 2001 Nov;1(3):175-8; discussion 179-81. doi: 10.3816/CCC.2001.n.018. Clin Colorectal Cancer. 2001. PMID: 12450432 Review.

5

Crohn's disease: ethnic variation in CARD15 genotypes.

Marsh S, McLeod HL. Marsh S, et al. Among authors: mcleod hl. Gut. 2003 May;52(5):770. doi: 10.1136/gut.52.5.770. Gut. 2003. PMID: 12692072 Free PMC article. No abstract available.

6

Pharmacogenetic analysis of clinically relevant genetic polymorphisms.

Rose CM, Marsh S, Ameyaw MM, McLeod HL. Rose CM, et al. Among authors: mcleod hl. Methods Mol Med. 2003;85:225-37. doi: 10.1385/1-59259-380-1:225. Methods Mol Med. 2003. PMID: 12710211 Review. No abstract available.

7

Use of pyrosequencing to detect clinically relevant polymorphisms in dihydropyrimidine dehydrogenase.

Ahluwalia R, Freimuth R, McLeod HL, Marsh S. Ahluwalia R, et al. Among authors: mcleod hl. Clin Chem. 2003 Oct;49(10):1661-4. doi: 10.1373/49.10.1661. Clin Chem. 2003. PMID: 14500593 No abstract available.

8

Ferredoxin reductase: pharmacogenomic assessment in colorectal cancer.

Yu J, Marsh S, Ahluwalia R, McLeod HL. Yu J, et al. Among authors: mcleod hl. Cancer Res. 2003 Oct 1;63(19):6170-3. Cancer Res. 2003. PMID: 14559799

9

Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin.

Gage BF, Eby C, Milligan PE, Banet GA, Duncan JR, McLeod HL. Gage BF, et al. Among authors: mcleod hl. Thromb Haemost. 2004 Jan;91(1):87-94. doi: 10.1160/TH03-06-0379. Thromb Haemost. 2004. PMID: 14691573

10

Cancer pharmacogenetics.

Marsh S, McLeod HL. Marsh S, et al. Among authors: mcleod hl. Br J Cancer. 2004 Jan 12;90(1):8-11. doi: 10.1038/sj.bjc.6601487. Br J Cancer. 2004. PMID: 14710198 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

589 results

Search Page

Filters